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Introduction: Prisons worldwide have 
been cited as reservoirs for 
tuberculosis and also an ideal setting 
for interventions but little is known 
about the epidemiology and control of 
tuberculosis in Nigerian Prisons.  
Objective: To determine the 
prevalence of tuberculosis, role of 
prison in its control and the mortality 
from tuberculosis among prison inmate 
in Kuje prison, Abuja, Nigeria.  
Materials and Methods: This study 
was a retrospective study of cases of 
tuberculosis in Kuje prison between 
April, 2004 and December, 2008. Data 
was collected from their medical 
records. The inclusion criterion was: 
(1) Cases of tuberculosis in which the 
diagnosis was based on clinical 
history, smear positive test and chest 
x-ray radiograph. (2) Cases where the 
treatment of tuberculosis was 
according to treatment strategy 
recommended by World Health 
Organization.  
Results: A total of forty-eight inmates, 
aged 20 to 45years, were diagnosed 
with tuberculosis within the period of 
interest. The prevalence rate was 
2.4%, based on a total prison 
population of 2002. Majority of cases 
93.8% were first detected in Prison 
and the remaining 6.3% were detected 
prior to incarceration. Out of the 6.3% 
diagnosed prior to incarceration, 2.1% 
and 4.2% of cases have defaulted 
from DOTS for 2weeks and more than 
4weeks respectively.  
Majority (66.7%) completed the 
treatment before discharging from 
prison, 29.2% were discharged from 
prison at various level of treatment and 
4.2% of cases died while on treatment. 
Those who died were co-infected with 
HIV  
Conclusion: It was evident from this 
study that: The prevalence of 
tuberculosis in Kuje prison was high, 
prison has a role in diagnosis and 
treatment, adherence and treatment 
outcome were good and the main 
indicator for mortality was HIV 
infection.  
Primary prevention measures 
specifically targeting prisoners are 
needed to reduce prevalence of 
tuberculosis and also to achieve the 
objectives of National Health Policy on 
tuberculosis and leprosy.  




Tuberculosis (TB) is an infectious 
disease caused by mainly 
Mycobacterium tuberculosis in 
humans1. Other mycobacteria such as 
Mycobacterium bovis, Mycobacterium 
africanum, Mycobacterium canetti, and 
Mycobacterium microti are significant 
cause of TB in some parts of Africa2,3.  
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Tuberculosis is the most frequently 
occurring infectious disease in the 
world and also stands out as a major 
cause of morbidity, disability and death 
globally4. It accounts for 2-3 million 
deaths per annum, globally4,5. In 2006, 
a total of 1.7 million people died of TB 
including 231,000 people with HIV6. 
One-third of the world's current 
population has been infected with M. 
tuberculosis, and new infections occur 
at a rate of one per second4-6,7. 
Approximately 95% of new cases and 
98% of deaths occur in developing 
nations. This is probably due limited 
resources availability and higher 
human immunodeficiency virus (HIV) 
infections5. The annual incidence rate 
is 356 per 100,000 cases in Africa6.  
In 1993, the World Health Organization 
(WHO) declared TB as a global 
emergency.  This is first disease so 
classified in the history of that 
organization and the Stop TB 
Partnership developed a Global Plan 
to Stop Tuberculosis with the aim of 
saving 14 million lives between 2006 
and 20158. TB is one of the few 
diseases for which specific control 
targets have been set in the 
Millennium Development Goals9.  It 
directly causes an annual decline in 
workers productivity to the tune of 
US$13 billion. TB is contagious and 
spreads through the air. If untreated, 
each person with active TB infects on 
average of 10 to 15 people every 
year6. The probability of transmission 
from one person to another depends 
upon the number of infectious droplets 
expelled by a carrier, the effectiveness 
of ventilation, the duration of exposure, 
and the virulence of the M. 
tuberculosis strain10.  
Prisoners population represent a high 
proportion of poorly educated and 
socioeconomically disadvantaged who 
have increased risk of ill health, 
including a high risk of tuberculosis 
infection and disease. Other conditions 
that increase the risk include 
intravenous drug abuse; overcrowding, 
poor nutrition, poor hygiene, and 
unguaranteed access to improved 
prison health services. The prison 
population has a high burden of 
disease may be  because access to 
medical care is limited and the 
population is made of substance 
abusers, homeless, mentally ill, ethnic 
minorities, asylum seekers, 
immigrants, people who inject drugs 
using unsanitary needles, medically 
under-served and low-income 
populations11-19.  
In tuberculosis control, health workers' 
caliber and adequacy largely 
determine the program quality and 
efficiency, as workers consume the 
bulk of running costs and manage the 
other resources. The World Health 
Organization (WHO) Global Plan to 
Stop TB 2006 – 2015 acknowledges 
that the main human resource issues 
affecting tuberculosis control are 
insufficient quality, quantity and 
distribution of health workers20.  
Tuberculosis is diagnosed definitively 
by identifying the causative organism 
in a clinical sample like sputum or pus. 
When this is not possible, a probable 
diagnosis may be made using imaging, 
commonly chest X-rays and/or a 
tuberculin skin test. The DOTS 
(Directly Observed Treatment Short-
course) is now showing promising 
results in effectively treating all TB in 
the community. This is strategy of 
tuberculosis treatment based on 
clinical trials done in the 1970s by 
Tuberculosis Research Centre, 
Chennai, India, focusing on a 
neglected area of infectious disease 
control is now showing promising 
results in effectively treating all TB 
cases in the community.  
There is dearth of information about 
TB in the Nigerian prisons and Nigeria 
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being said to have the world’s fourth 
largest tuberculosis (TB) burden, with 
more than 460,000 estimated new 
cases in 200721. 
The objective of this study was to 
determine the prevalence of 
tuberculosis, role of prison in its control 
and the mortality from tuberculosis 
among prison inmate in Kuje prison, 
Abuja, Nigeria.  
 
MATERIALS AND METHODS 
This was a retrospective study of 
cases of Tuberculosis in Kuje Prison 
between April 2004 and December 
2008.  The inclusion criteria include: 
1. Cases of tuberculosis in which the 
diagnosis was made on clinical 
history, smear positive test and 
chest radiograph. 
2. Cases of TB where treatment of 
tuberculosis was according to the 
treatment strategy recommended 




A total of number of inmates recorded 
over the study period was 2002 with 
awaiting trial as 1654 (82.6%) and 
convict as 348 (17.4%). the ratio of 
convict to awaiting trial inmates was 
1:4.8. The population of inmates 
increased steadily over the study 
period except in 2008 when a decline 
was seen (Table I). A total of forty-
eight inmates, aged 20 to 45years, 
were diagnosed with tuberculosis 
within the period of interest. There 
were all awaiting trial inmates. The 
prevalence rate was 2.4%. 
 
 
Table I: NO OF INMATES WITHIN STUDY PERIOD 
 
Year   Awaiting Trial (%) Convicted (%)    Total (%)  
2004   258 (15.6)  42 (12.1)      300 (15.0) 
2005   215 (13.0)  65 (18.7)       280 (14.0) 
2006   327 (19.8)  71 (20.4)       398 (19.9) 
2007   453 (27.4)  88 (25.3)       541 (27.0) 
2008   401 (24.2)  82 (23.6)       483 (24.1) 
Total   1654 (100)  348 (100)      2002(100)
 
 
Benin Journal of Postgraduate Medicine  M.A Lawal, M. Omili, T.O Bello, L. Onuha, A. Haruna. 
 4  
 




Majority of cases 93.8% were first 
detected in Prison and the remaining 
6.3% were detected prior to 
incarceration (Fig. I). Out of the 6.3%
 diagnosed prior to incarceration, 2.1% 
and 4.2% of cases have defaulted 
from DOTS for 2 weeks and more than 
4 weeks respectively.  
 





Majority 66.7% completed the 
treatment before discharging from 
prison, 29.2% were discharged from 
prison at various level of treatment and
 4.2% of cases died while on treatment 
(Fig. II). Those that were co-infected 
with HIV died in the course of the 
treatment (Fig. III). 
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Fig. III: CO-INFECTION WITH HIV 
 
 
         
DISCUSSION 
TB occurs predominantly in resource-
limited countries and represents a 
substantial public health problem in 
low- and middle-income countries. The 
World Health Organization and the 
International Committee of the Red 
Cross have joined forces to produce 
guidelines for the control of tuberculosis 
in prisons and similar institutions in 
countries with a high prevalence of 
tuberculosis. The internationally 
recommended strategy for tuberculosis 
control relies on early detection and 
cure of patients, with a priority for 
infectious cases. Screening of prisoners 
on entry into prison may have a role in 
early case detection. This is reflected 
by the study as 10% in this study were 
already being diagnosed with 
tuberculosis before incarceration. 
Overcrowding, poor nutrition, poor 
hygiene and long prison sentences 
promote tuberculosis. These are 
dominant features of Nigeria prisons 
and this may explain why 90% of cases 
were first diagnosed in prison. 
Overcrowding, poor ventilation, poor 
nutrition and inadequate or inaccessible 
medical care can facilitate the spread of 
disease in the prisons. 
Prisons act as a reservoir for TB, 
pumping the disease into the civilian 
community through staff, visitors and 
inadequately treated former inmates22. 
Therefore, improving TB control in 
prisons will benefit the community at 
large. Community TB control efforts 
cannot afford to ignore prison TB. 
Most prisoners come from 
underprivileged sectors of the general 
population and are more likely to have 
contracted tuberculosis before their 
arrival in prison.  
The prevalence of 2.4% recorded in this 
study is lower than 4.0% recorded in 
Zambian prisons23. All the cases of TB 
in this study were inmates of awaiting 
trial. This group poses a lot of risk as 
they come in contact with many people 
as they are moved from prisons to court 
rooms and when they receive visitors 
ranging from lawyers, human right 
groups and family members. 
Certain features of the prison 
environment provide an opportunity to 
implement effective control 
programmes. For example, the captive 
audience in prisons should facilitate 
direct observation of treatment, 
complete coverage, and health 
education. In this present study, quite a 
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high number (64%) completed their 
treatment of tuberculosis while still in 
prison and 32% discharged at different 
level of treatment were adequately 
motivated to complete the treatment 
outside the prison in DOTS near their 
residence. 
 Judicial services are slow and this has 
been condemned in many quarters. 
This long stay before trial served as an 
opportunity to achieve complete 
treatment of tuberculosis in two third 
(66.7%) of the affected group. Long 
duration of antituberculosis negatively 
impacts on adherence to therapy. In 
this study, previously diagnosed 
inmates before incarceration defaulted. 
Confinements removed cases of 
defaulting which is a positive side of 
imprisonment. This substantiated the 
fact that a prison is a control setting for 
TB control24,25. 
Tuberculosis is a leading cause 
worldwide of morbidity and mortality 
among HIV-infected people26. In this 
study, the mortality rate was 4.2%. The 
co-infection with HIV infection was the 
predictor of mortality. Prison conditions, 
tuberculosis, and HIV transmission are 
interconnected. Prevalence of HIV is 
higher in prison than the society due 
Illegal drug use, Sex between men, 
voluntary or forced, and rare use of 
condoms27,28. The HIV epidemic 
complicates control of tuberculosis in 
prisons. This is confirmed in this study 
as 4.2% of cases were HIV-infected 




It was evident from the study that the 
prison has a role in the diagnosis and 
treatment of TB. Mortality was low and 
the main indicator was HIV infection. 
Adherence and treatment outcome 
were good. Emphasis should be placed 
on primary prevention to reduce the 
prevalence of tuberculosis in prison. It 
is also recommended that prisons 
should be well-ventilated, overcrowding 
should be prevented and good nutrition 
provided to reduce the tuberculosis 
prevalence to the barest minimum 
inorder to achieve the objectives of 
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